Goldman Sachs’s Sensus Healthcare SRTS Stock Holding History

Goldman Sachs’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,880	Closed	-$61.1K	–	6636
2025 Q2	$61.1K	Buy	+12,880	New	+$60.3K	﹤0.01%	5887
2025 Q1	–	Sell	-100,171	Closed	-$693K	–	6385
2024 Q4	$693K	Buy	100,171 +86,126	+613%	+$631K	﹤0.01%	5058
2024 Q3	$81.5K	Sell	14,045 -19,736	-58%	-$120K	﹤0.01%	5592
2024 Q2	$180K	Buy	+33,781	New	+$155K	﹤0.01%	5296
2023 Q1	–	Sell	-13,454	Closed	-$99.8K	–	6210
2022 Q4	$99.8K	Buy	+13,454	New	+$121K	﹤0.01%	5479
2022 Q3	–	Sell	-20,321	Closed	-$156K	–	6526
2022 Q2	$156K	Sell	20,321 -20,985	-51%	-$176K	﹤0.01%	5722
2022 Q1	$418K	Buy	41,306 +21,717	+111%	+$198K	﹤0.01%	5445
2021 Q4	$141K	Buy	+19,589	New	+$107K	﹤0.01%	6021
2019 Q2	–	Sell	-12,620	Closed	-$89K	–	5339
2019 Q1	$89K	Buy	+12,620	New	+$97.5K	﹤0.01%	4941
2017 Q4	–	Sell	-34,627	Closed	-$172K	–	6638
2017 Q3	$172K	Buy	+34,627	New	+$170K	﹤0.01%	5835

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

MIM

Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Goldman Sachs's SRTS Position: Q3 2025 in Review

Goldman Sachs sold out of Sensus Healthcare (SRTS) in Q3 2025, closing a stake of 12,880 shares — an estimated $61.1K sold.

Goldman Sachs first reported a position in SRTS in Q3 2017 and held it in 10 quarters. The position peaked at $693K in Q4 2024. 42 funds tracked by Wall St. Rank hold SRTS as of Q3 2025.

Goldman Sachs reported no remaining Sensus Healthcare position as of Q3 2025 after selling out during the quarter.
Goldman Sachs sold 12,880 Sensus Healthcare shares in Q3 2025, an estimated $61.1K.
Goldman Sachs first reported a position in Sensus Healthcare in Q3 2017 and held it in 10 quarters.
Goldman Sachs's Sensus Healthcare position peaked at $693K in Q4 2024.
42 funds tracked by Wall St. Rank held Sensus Healthcare as of Q3 2025.

Based on Goldman Sachs's 13F filing for Q3 2025, filed 14 Nov 2025.